Yindjibarndi Appeals Fortescue Mining Compensation Ruling 
Glastonbury is as popular than ever, but complaints about the lineup reveal its generational challenge 
BOJ’s Himino Signals Timely Rate Hikes as Inflation Risks Rise 
Why a ‘rip-off’ degree might be worth the money after all – research study 
Locked up then locked out: how NZ’s bank rules make life for ex-prisoners even harder 
The pandemic is still disrupting young people’s careers 
Gold Prices Rise Toward $4,650 Ahead of Warsh’s Jackson Hole Speech 
SoftBank Eyes $20 Billion Bond Sale to Refinance OpenAI Loan 
Office design isn’t keeping up with post-COVID work styles - here’s what workers really want 
Trump Administration Plans New Drug Pricing Deals With Biotech Firms 
Dollar Steady Ahead of Jackson Hole as Yen Holds Firm 
OpenAI AI Agent Swarm Behind Hugging Face Hack 
Asian Stocks Slip Ahead of Nvidia Earnings and US Inflation Data 
Heritage, desire and diplomacy: why China still values scotch whisky 
Luxshare Shares Rise as First-Half Profit Jumps 18% 
BofA Names ASML Top Semiconductor Equipment Pick on Growth, Valuation 
Add as a preferred source on Google
Colgate-Palmolive plans to buy three pet food plants from Red Collar Pet Foods for $700 million to support the capital expenditures of its Hill’s Science Diet division business for pet foods.
Those plants, in Orangeburg, S.C.; Clinton, Okla., and Washington Court House, Ohio, will produce dry pet food, and approximately 350 employees will be offered jobs at Colgate-Palmolive.
In addition, the company is currently building a new canned pet food plant in Tonganoxie, Kansas, scheduled to begin production next year, and acquired a canned pet food plant in Italy in April.
The Hill’s Science Diet division had the fastest growth of any major Colgate-Palmolive division in the quarter ending in July.
Hill’s operating profit for that quarter was $212 million, which was about 24 percent of the profit for the company as a whole. Net sales for Hill’s products were up 15 percent, and organic sales up 18 percent.
CEO Noel Wallace said that with their business growing well, they will continue to invest to expand production capacity, improve their capabilities with initiatives like their new Small Paws Innovation Center, and better engage pet parents, veterinarians, and their retail partners.
